Skip to main content
. 2022 Sep 21:10.1111/ene.15546. Online ahead of print. doi: 10.1111/ene.15546

TABLE 1.

Overview of patient characteristics, history, vaccination‐related symptoms, and results of audiovestibular testing in the subgroup of COVID‐19‐related vestibular syndromes (n = 72)

PPPD/FD VM PPPD/FD + VM BPPV UVP MD VP Other
Patient characteristics
n (%) 25 (34.7%) 14 (19.4%) 13 (18.1%) 9 (12.5%) 3 (4.2%) 3 (4.2%) 2 (2.8%) 3 (4.2%)
Female/male, n 10/15 12/2 12/1 7/2 2/1 2/1 0/2 0/3
Age, years 44.4 ± 13.9 42.1 ± 13.4 39.1 ± 11.6 66.3 ± 14.2 45.4 ± 5.9 52.7 ± 5.8 55.4 ± 5.6 63.1 ± 11.4
Patient history, n
Preceding psychiatric disease 9 1 5 2 1
Headache 5 9 12 1 2
Vaccination‐related symptoms, n
General reaction 9 1 2 1 3 1 1
Migrainelike symptoms 9 6 2
Onset of vestibular symptoms (postvaccination)
0–24 h 1 7 7 4 1 1 1
1–7 days 10 4 2 5 2
2–4 weeks 14 3 4 2 2 1 1
Audiovestibular testing, n
Peripheral vestibular function
Normal 23 12 13 6 1 2 2
Old unilateral deficit 2 1 2 1 1
Old bilateral deficit 1 1
New unilateral deficit 3 1
New bilateral deficit
Central vestibular function
Central vestibular/ocular motor signs 1
Acute vestibular tone imbalance 2 1
Posturography
PPPD/FD sway 11 1
Normal 12 4 10 1 1 1 1
Hearing function
Normal 23 14 12 6 3 2 3
New or worsening of hearing dysfunction 3

Abbreviations: BPPV, benign peripheral paroxysmal vertigo; MD, Ménière disease; PPPD/FD, persistent postural perceptual dizziness/functional dizziness; UVP, unilateral vestibulopathy; VM, vestibular migraine; VP, vestibular paroxysmia.